< Back to all Breaking News
CERE
10/30/2020 07:10am
Cerevel Therapeutics doses first patients in Phase 3 trials of tavapadon
Don't miss out!
We read the Wall Street research, SEC filings and press releases so you don't have to.
Sign up for our 14-day free trial to read this story.